Treatment duration of febrile urinary tract infection (FUTIRST trial): A randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days)

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  van Nieuwkoop, Cees ^a   van't Wout, Jan W ^a,b   Assendelft, Willem J J ^a   Elzevier, Henk W ^a   Leyten, Eliane M S ^b   Koster, Ted ^c   Wattel Louis, G Hanke ^d   Delfos, Nathalie M ^e   Ablij, Hans C ^f   Kuijper, Ed J ^a   Pander, Jan ^a   Blom, Jeanet W ^a   Spelt, Ida C ^g   van Dissel, Jaap T ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c GROENE HART HOSPITAL   (Netherlands)

^d Infection and Immunology   (Netherlands)

^e RIJNLAND HOSPITAL   (Netherlands)

^f Rijnland Hospital ^*  (Netherlands)

^g Primary Health Care Center   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; GENTAMICIN; NITRATE; PLACEBO; ANTIINFECTIVE AGENT; BETA LACTAM;

ACUTE PYELONEPHRITIS; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HUMAN; LEUKOCYTURIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SHORT COURSE THERAPY; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; URINALYSIS; COMPARATIVE STUDY; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CIPROFLOXACIN; DOUBLE-BLIND METHOD; FEMALE; FEVER; GENTAMICINS; HUMANS; MALE; URINARY TRACT INFECTIONS;

EID: 69849107240     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-131     Document Type: Article

References (35)

1. Pinson AG Philbrick JT Lindbeck GH Schorling JB Fever in the clinical diagnosis of acute pyelonephritis Am J Emerg Med 1997, 15:148-151. 10.1016/S0735-6757(97)90087-5 9115515
2. Piccoli GB Consiglio V Colla L Mesiano P Magnano A Burdese M Marcuccio C Mezza E Veglio V Picolli G Antibiotic treatment for acute 'uncomplicated' or 'primary' pyelonephritis: A systematic, 'semantic revision' Int J Antimicrob Agents 2006, 28(Suppl 1):S49-S63. 10.1016/ j.ijantimicag.2006.05.017 16854569
3. Brown P Ki M Foxman B Acute pyelonephritis among adults: Cost of illness and considerations for the economic evaluation of therapy Pharmacoeconomics 2005, 23:1123-1142. 10.2165/00019053-200523110-00005 16277548
4. Nicolle LE Friesen D Harding GK Roos LL Hospitalization for acute pyelonephritis in Manitoba, Canada, during the period from 1989 to 1992; impact of diabetes, pregnancy, and aboriginal origin Clin Infect Dis 1996, 22:1051-1056. 8783709
5. Foxman B Klemstine KL Brown PD Acute pyelonephritis in US hospitals in 1997: Hospitalization and in-hospital mortality Ann Epidemiol 2003, 13:144-150. 10.1016/S1047-2797(02)00272-7 12559674
6. Czaja CA Scholes D Hooton TM Stamm WE Population-Based Epidemiologic Analysis of Acute Pyelonephritis Clin Infect Dis 2007, 45:273-280. 10.1086/519268 17599303
7. Stamm WE McKevitt M Counts GW Acute renal infection in women: Treatment with trimethoprim-sulfamethoxazole or ampicillin for two or six weeks. A randomized trial Ann Intern Med 1987, 106:341-345. 3492950
8. Mombelli G Pezzoli R Pinoja-Lutz G Monotti R Marone C Franciolli M Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: A prospective randomized clinical trial Arch Intern Med 1999, 159:53-58. 10.1001/archinte.159.1.53 9892331
9. Talan DA Stamm WE Hooton TM Moran GJ Burke T Iravani A Reuning-Scherer J Church DA Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: A randomized trial JAMA 2000, 283:1583-1590. 10.1001/jama.283.12.1583 10735395
10. Klausner HA Brown P Peterson J Kaul S Khashab M Fisher AC Kahn JB A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis Curr Med Res Opin 2007, 23:2637-2645. 10.1185/ 030079907X233340 17880755
11. Warren JW Abrutyn E Hebel JR Johnson JR Schaeffer AJ Stamm WE Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA) Clin Infect Dis 1999, 29:745-758. 10.1086/520427 10589881
12. Hooton TM The current management strategies for community-acquired urinary tract infection Infect Dis Clin North Am 2003, 17:303-332. 10.1016/S0891-5520(03)00004-7 12848472
13. Rubenstein JN Schaeffer AJ Managing complicated urinary tract infections: The urologic view Infect Dis Clin North Am 2003, 17:333-351. 10.1016/S0891-5520(03)00012-6 12848473
14. Ramakrishnan K Scheid DC Diagnosis and management of acute pyelonephritis in adults Am Fam Physician 2005, 71:933-942. 15768623
15. Nicolle LE Short-term therapy for urinary tract infection: Success and failure International Journal of Antimicrobial Agents 2008, 31:40-45. 10.1016/j.ijantimicag.2007.07.040
16. ACOG Practice Bulletin No. 91: Treatment of urinary tract infections in nonpregnant women Obstet Gynecol 2008, 111:785-794. 18310389
17. Mehlhorn AJ Brown DA Safety concerns with fluoroquinolones Ann Pharmacother 2007, 41:1859-1866. 10.1345/aph.1K347 17911203
18. Iannini PB The safety profile of moxifloxacin and other fluoroquinolones in special patient populations Curr Med Res Opin 2007, 23:1403-1413. 10.1185/030079907X188099 17559736
19. Rubin RH Shapiro ED Andriole VT Davis RJ Stamm WE Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration Clin Infect Dis 1992, 15(Suppl 1):S216-27. S216-S227. 1477233
20. Naber KG Experience with the new guidelines on evaluation of new anti-infective drugs for the treatment of urinary tract infections Int J Antimicrob Agents 1999, 11:189-196. 10.1016/S0924-8579(99)00014-X 10394969
21. van Nieuwkoop C van't Wout JW Spelt I Numan-Ruberg SC Häcker EL van Dissel JT Treatment of febrile urinary tract infection in the elderly and male at primary care and emergency department 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 2007. Abstract L-497.
22. D'Agostino RB Sr Massaro JM Sullivan LM Non-inferiority trials: Design concepts and issues - the encounters of academic consultants in statistics Stat Med 2003, 22:169-186. 10.1002/sim.1425 12520555
23. Zwarenstein M Treweek S Gagnier JJ Altman DG Tunis S Haynes B Oxman AD Moher D Improving the reporting of pragmatic trials: An extension of the CONSORT statement BMJ 2008, 337:a2390. 10.1136/bmj.a2390 19001484
24. Piaggio G Elbourne DR Altman DG Pocock SJ Evans SJ Reporting of noninferiority and equivalence randomized trials: An extension of the CONSORT statement JAMA 2006, 295:1152-1160. 10.1001/jama.295.10.1152 16522836
25. Schaeffer AJ Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome N Engl J Med 2006, 355:1690-1698. 10.1056/ NEJMcp060423 17050893
26. Kunin CM Definition of acute pyelonephritis vs the urosepsis syndrome Arch Intern Med 2003, 163:2393-2394. 10.1001/archinte.163.19.2393-b 14581259
27. Sandberg T Englund G Lincoln K Nilsson LG Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis Eur J Clin Microbiol Infect Dis 1990, 9:317-323. 10.1007/BF01973737 2197091
28. Cox CE Marbury TC Pittman WG Brown GL Auerbach SM Fox BC Yang JY A randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis Clin Ther 2002, 24:223-236. 10.1016/ S0149-2918(02)85019-6 11911553
29. Naber KG Bartnicki A Bischoff W Hanus M Milutinovic S van Belle F Schönwald S Weitz P Ankel-Fuchs D Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections Int J Antimicrob Agents 2004, 23(Suppl 1):S41-53. S41-S53. 10.1016/j.ijantimicag.2003.09.002 15037328
30. Talan DA Klimberg IW Nicolle LE Song J Kowalsky SF Church DA Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis J Urol 2004, 171:734-739. 10.1097/ 01.ju.0000106191.11936.64 14713799
31. Peterson J Kaul S Khashab M Fisher AC Kahn JB A Double-Blind, Randomized Comparison of Levofloxacin 750 mg Once-Daily for Five Days With Ciprofloxacin 400/500 mg Twice-Daily for 10 Days for the Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis Urology 2008, 71:17-22. 10.1016/j.urology.2007.09.002 18242357
32. Ulleryd P Sandberg T Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: A randomized trial with a 1 year follow-up Scand J Infect Dis 2003, 35:34-39. 10.1080/0036554021000026988 12685882
33. van Haaren KAM Visser HS van Vliet S Timmermans AE Yadava R Geerlings SE ter Riet G van Pinxteren B NHG-Standaard Urineweginfecties: Tweede herziening [Guideline of the Dutch College of General Practitioners on urinary tract infections: Second revision] Huisarts Wet 2005, 48:341-352.
34. Grabe M Bishop MC Bjerklund-Johansen TE Botto H Cek M Lobel B Naber KG Palou J Tenke P Guideline on the management of urinary and male genital tract infections. European Association of Urology http://www.uroweb.org/ nc/professional-resources/guidelines/online
35. Tunis SR Stryer DB Clancy CM Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy JAMA 2003, 290:1624-1632. 10.1001/jama.290.12.1624 14506122